Navigation Links
Proper Intake Of Medicine Provides Relief; Discontinue Medication, Continue Suffering

Attention deficit-hyperactivity disorder (ADHD), is a common neurobehavioral disorder. Children found affected with this disease are prescribed// stimulant medications. A new study indicates that due to social stigma and feeling lifeless and/or alienated from one’s peers, children and adolescents discontinue medications.

ADHD is affecting 4.4 million children in the United States between the ages of 4 and 17. Following diagnosis, 56% are treated with prescription stimulant medications. According to the study, many stop using these medications even while they are still exhibiting symptoms of the disorder, despite research indicating these medications are effectively reducing hyperactivity, impulsivity and inattention.

The study also found that while ADHD is a chronic disorder, none of the adolescents interviewed had received ongoing education about their condition. As college students, many used the medications irregularly, sometimes in doses exceeding the prescribed amount, and often at night – factors that may exacerbate the side effects.

Julie B. Meaux, PhD, RNC, lead author of the study, suggests that “dialogue between the child, parents and healthcare provider about the general effects, side effects and potential abuse of prescribed stimulant medications is essential,” adding “careful administration of dosages, based on input from the child, is exceedingly important.”

Source-EurekalertPRI
'"/>




Page: 1

Related medicine news :

1. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
2. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
3. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
4. Fruits And Vegetables Have Arthritis Risk Reducing Property
5. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
6. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
7. Colon Cancer Patients Not Receiving Proper Treatment
8. Proper Diet Can Counter Macular Degeneration
9. Scots Do Not Have Access To Proper Dental Care
10. Risk Of Stroke Can Be Lessened By Proper Diet
11. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... ... excited to announce the next generation for LASIK in Manhattan with Contoura Vision, ... most technologically advanced laser systems available in the United States to correct nearsightedness ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... Community”: a gripping look at the religious stand in the sensitive matter ... love and compassion. “The Ministry of Reconciliation: A Compassionate and Realistic Approach to ...
(Date:9/25/2017)... ... ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the New ... with the new NEXTY Gold Award at the Natural Products Expo East trade show ... is reserved for just those companies that hit high marks on the criteria of ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... September 28, 2017 to deliver a powerful message of teamwork, unity and collaboration ... Feature film writer/director Robert Adetuyi (Beat the World, Stomp the Yard) and Grammy-nominated ...
(Date:9/24/2017)... Michigan (PRWEB) , ... September 23, 2017 , ... Throughout ... do no harm. , Every day, physicians, nurses and other providers work to ... treatments and innovative industry processes. , But U.S. Senators today are threatening to ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
Breaking Medicine Technology: